Literature DB >> 30388200

Telomeres Increasingly Develop Aberrant Structures in Aging Humans.

Virginia Boccardi1, Luigi Cari2, Giuseppe Nocentini2, Carlo Riccardi2, Roberta Cecchetti1, Carmelinda Ruggiero1, Beatrice Arosio3,4, Giuseppe Paolisso5, Utz Herbig6, Patrizia Mecocci1.   

Abstract

Telomeres progressively shorten with age, and it has been proposed that critically short and dysfunctional telomeres contribute to aging and aging-associated diseases in humans. For many years it was thought that telomere erosion was strictly a consequence of the "end replication problem," or the inability of replicative polymerases to completely duplicate linear DNA ends. It is becoming increasingly evident, however, that telomere shortening of cultured human cells is also caused because of other replication defects in telomeric repeats, those that cause fragile telomeres and other aberrant telomeric structures that can be detected on metaphase chromosomes. Whether these replication defects contribute to telomere erosion also in human tissues is currently unknown. By analyzing peripheral blood mononuclear cells from a total of 35 healthy subjects ranging in age from 23 to 101 years, we demonstrated that telomeres increasingly display aberrant structures with advancing donor age. Although the percentages of fragile telomeres increased only until adulthood, the percentages of chromosomes displaying sister telomere loss and sister telomere chromatid fusions increased consistently throughout the entire human life span. Our data, therefore, suggest that telomeric replication defects other than the end replication problem contribute to aging-associated telomere erosion in humans.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Health; Human aging; Telomeres

Year:  2020        PMID: 30388200      PMCID: PMC7176058          DOI: 10.1093/gerona/gly257

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  24 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

2.  Cellular senescence in aging primates.

Authors:  Utz Herbig; Mark Ferreira; Laura Condel; Dee Carey; John M Sedivy
Journal:  Science       Date:  2006-02-02       Impact factor: 47.728

3.  Leukocyte telomere length and prevalence of age-related diseases in semisupercentenarians, centenarians and centenarians' offspring.

Authors:  Enzo Tedone; Beatrice Arosio; Cristina Gussago; Martina Casati; Evelyn Ferri; Giulia Ogliari; Francesco Ronchetti; Alessandra Porta; Francesca Massariello; Paola Nicolini; Daniela Mari
Journal:  Exp Gerontol       Date:  2014-06-27       Impact factor: 4.032

4.  Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions.

Authors:  Yun Lin; Amanda Damjanovic; E Jeffrey Metter; Huy Nguyen; Thai Truong; Kevin Najarro; Christa Morris; Dan L Longo; Ming Zhan; Luigi Ferrucci; Richard J Hodes; Nan-ping Weng
Journal:  Clin Sci (Lond)       Date:  2015-03       Impact factor: 6.124

Review 5.  Human telomere biology: pitfalls of moving from the laboratory to epidemiology.

Authors:  Abraham Aviv; Ana M Valdes; Tim D Spector
Journal:  Int J Epidemiol       Date:  2006-09-22       Impact factor: 7.196

6.  Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.

Authors:  Agnel Sfeir; Settapong T Kosiyatrakul; Dirk Hockemeyer; Sheila L MacRae; Jan Karlseder; Carl L Schildkraut; Titia de Lange
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

7.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

8.  Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.

Authors:  Graeme Hewitt; Diana Jurk; Francisco D M Marques; Clara Correia-Melo; Timothy Hardy; Agata Gackowska; Rhys Anderson; Morgan Taschuk; Jelena Mann; João F Passos
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

9.  Stn1 is critical for telomere maintenance and long-term viability of somatic human cells.

Authors:  Virginia Boccardi; Neetu Razdan; Jessica Kaplunov; Jyoti J Mundra; Masayuki Kimura; Abraham Aviv; Utz Herbig
Journal:  Aging Cell       Date:  2015-02-14       Impact factor: 9.304

10.  Defective repair of oxidative base lesions by the DNA glycosylase Nth1 associates with multiple telomere defects.

Authors:  Haritha Vallabhaneni; Nathan O'Callaghan; Julia Sidorova; Yie Liu
Journal:  PLoS Genet       Date:  2013-07-18       Impact factor: 5.917

View more
  3 in total

Review 1.  Genome-Protecting Compounds as Potential Geroprotectors.

Authors:  Ekaterina Proshkina; Mikhail Shaposhnikov; Alexey Moskalev
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

2.  Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer's disease.

Authors:  Seong-Ho Koh; Seong Hye Choi; Jee Hyang Jeong; Jae-Won Jang; Kyung Won Park; Eun-Joo Kim; Hee Jin Kim; Jin Yong Hong; Soo Jin Yoon; Bora Yoon; Ju-Hee Kang; Jong-Min Lee; Hyun-Hee Park; Jungsoon Ha; Young Ju Suh; Suyeon Kang
Journal:  Aging (Albany NY)       Date:  2020-03-03       Impact factor: 5.682

3.  Telomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening.

Authors:  Mariarosaria de Rosa; Sanjana A Thosar; Ryan P Barnes; Ariana C Detwiler; Vera Roginskaya; Bennett Van Houten; Marcel P Bruchez; Jacob Stewart-Ornstein; Patricia L Opresko
Journal:  Nat Struct Mol Biol       Date:  2022-06-30       Impact factor: 18.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.